Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
SSE:688068
Price:
29.43 CNY
3.48%
Updated:
Apr 29, 2024
Beijing Hotgen Biotech Co Ltd
Net Income (Common)
|
Beijing Hotgen Biotech Co Ltd
Net Income (Common) Peer Comparison
Comparables:
603259
300759
2269
300347
W
2268
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Net Income (Common)
¥944.7m
|
CAGR 3-Years
203%
|
CAGR 5-Years
99%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Net Income (Common)
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Net Income (Common)
¥1.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Net Income (Common)
¥3.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Net Income (Common)
¥2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
36%
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Net Income (Common)
¥155.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Net Income (Common)?
Net Income (Common)
944.7m
CNY
944.7m
CNY
Based on the financial report for Dec 31, 2022, Beijing Hotgen Biotech Co Ltd's Net Income (Common) amounts to 944.7m CNY.
What is Beijing Hotgen Biotech Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
99%
99%
Over the last year, the Net Income (Common) growth was -57%. The average annual Net Income (Common) growth rates for Beijing Hotgen Biotech Co Ltd have been 203% over the past three years , 99% over the past five years .
You don't have any saved screeners yet
